Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sepehr Nowfar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Transplantation|January 25, 2003
Internet use by a multidisciplinary transplant clinic populationDouglas P Slakey, Sepehr Nowfar
Journal of Healthcare Information Management : JHIM|February 20, 2004
Factors affecting patient-physician communication via the InternetDouglas P Slakey, Sepehr Nowfar
Timely Topics in Medicine. Cardiovascular Diseases|April 15, 2005
The impact of vascular risk factors on erectile functionMuammer Kendirci, Sepehr Nowfar, Wayne J G Hellstrom
Drugs of Today (Barcelona, Spain : 1998)|March 9, 2005
The impact of vascular risk factors on erectile functionMuammer Kendirci, Sepehr Nowfar, Wayne J G Hellstrom
Urology|June 17, 2011
The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasisSepehr Nowfar, Kerrin Palazzi-Churas, David C Chang, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|March 8, 2012
Initial experience with aspirin use during robotic radical prostatectomySepehr Nowfar, Ryan Kopp, Kerrin Palazzi-Churas, et al.
The Journal of Urology|July 12, 2005
The relationship between the type of penile abnormality and penile vascular status in patients with peyronie's diseaseMuammer Kendirci, Sepehr Nowfar, Serap Gur, et al.
The Journal of Sexual Medicine|January 21, 2006
The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's diseaseMuammer Kendirci, Mustafa F Usta, Richard V Matern, et al.
European Urology Focus|February 27, 2026
ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapyAndrew L Laccetti, Matthew R Smith, Howard I Scher, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Transplantation|January 25, 2003
Internet use by a multidisciplinary transplant clinic populationDouglas P Slakey, Sepehr Nowfar
Journal of Healthcare Information Management : JHIM|February 20, 2004
Factors affecting patient-physician communication via the InternetDouglas P Slakey, Sepehr Nowfar
Timely Topics in Medicine. Cardiovascular Diseases|April 15, 2005
The impact of vascular risk factors on erectile functionMuammer Kendirci, Sepehr Nowfar, Wayne J G Hellstrom
Drugs of Today (Barcelona, Spain : 1998)|March 9, 2005
The impact of vascular risk factors on erectile functionMuammer Kendirci, Sepehr Nowfar, Wayne J G Hellstrom
Urology|June 17, 2011
The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasisSepehr Nowfar, Kerrin Palazzi-Churas, David C Chang, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|March 8, 2012
Initial experience with aspirin use during robotic radical prostatectomySepehr Nowfar, Ryan Kopp, Kerrin Palazzi-Churas, et al.
The Journal of Urology|July 12, 2005
The relationship between the type of penile abnormality and penile vascular status in patients with peyronie's diseaseMuammer Kendirci, Sepehr Nowfar, Serap Gur, et al.
The Journal of Sexual Medicine|January 21, 2006
The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's diseaseMuammer Kendirci, Mustafa F Usta, Richard V Matern, et al.
European Urology Focus|February 27, 2026
ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapyAndrew L Laccetti, Matthew R Smith, Howard I Scher, et al.
Pageof 1